QUOTE AND NEWS
StreetInsider.com  May 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Anika+Therapeutics%2C+Inc.+%28ANIK%29+Misses+Q1+EPS+by+3c/7402441.html for the full story.
Business Wire  May 3  Comment 
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter ended March 31, 2012. Revenue For the first
Business Wire  Apr 26  Comment 
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2012 financial results after the close of the market on Thursday, May 3, 2012. The company plans to hold a conference call the next day, Friday, May 4,
Benzinga  Apr 9  Comment 
magicJack VocalTec Ltd (NASDAQ: CALL) shares moved up 12.20% to $23.35 at 10:20 am. The volume of CALL shares traded was 266% higher than normal. CALL projects to post a Q1 profit of $7.8 million. Anika Therapeutics Inc (NASDAQ: ANIK) shares...
Benzinga  Apr 9  Comment 
Verenium Corporation (NASDAQ: VRNM) shares jumped 3.79% to create a new 52-week high of $4.65. VRNM's trailing-twelve-month ROE is 79.89%. Global-Tech Advanced Innovations Inc (NASDAQ: GAI) shares gained 86.76% to touch a new 52-week high of...
Business Wire  Feb 29  Comment 
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter and full year ended December 31, 2011. Revenue
StreetInsider.com  Dec 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Anika+%28ANIK%29+Signs+Distribution+Agreement+with+DePuy+Mitek+for+MONOVISC/7037269.html for the full story.
StreetInsider.com  Nov 2  Comment 
Atrinsic (Nasdaq: ATRN) 20% LOWER; will voluntarily delist from the Nasdaq, sees shares trading in the OTC market. Anika Therapeutics, Inc. (NASDAQ: ANIK) 17% HIGHER; reported Q3 EPS of $0.22, vs. the analyst estimate of $0.11. Revenue for the...
StreetInsider.com  Aug 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Anika+Therapeutics%2C+Inc.+%28ANIK%29+Reports+Q2+Earnings+of+%240.17%2C+Revenues+Increase+YY/6687972.html for the full story.
StreetInsider.com  Jun 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Anika+%28ANIK%29+Unit+Enters+Hyalomatrix+Distribution+Agreement+with+Misonix+%28MSON%29/6553164.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki